Your browser does not support JavaScript!

Home    Search  

Results - Details

Search command : Author="Παπακωνσταντή"  And Author="Ευαγγελία"

Current Record: 7 of 15

Back to Results Previous page
Next page
Add to Basket
[Add to Basket]
Identifier 000396042
Title Αλληλεπίδραση μεσεγχυματικών κυττάρων (κυττάρων στρώματος) με υποπληθυσμούς αρχέγονων αιμοποιητικών κυττάρων
Alternative Title The role of bone marrow mesenchymal stromal cells in the ex vivo expansion of hematopoietic stem cells
Author Πελαγιάδης Ιορδάνης
Thesis advisor Δημητρίου, Ελένη
Στειακάκη, Ευτυχία
Ηλιόπουλος, Αριστείδης
Reviewer Παπαδάκη Ελένη
Αλεξανδράκης, Μιχαήλ
Ρελάκης, Κωνσταντίνος
Παπακωνσταντή, Ευαγγελία
Abstract Introduction The recognition of the role of the mesenchymal stromal cells (MSC) in hematopoiesis, as part of the bone marrow microenvironment, has renewed the interest in the ex vivo expansion of the cord blood (CB) as a source of hematopoietic stem cell (HSC) for transplantation. Children’s MSC appear to have different biological properties compared to the adult counterpart. The cord blood is a rich source of stem cells, whose characterization and isolation requires both specific indicators - such as the surface antigen CD34 and the corresponding CD133 - as well as reliable and reproducible protocols. In the present study we initially assessed the isolation protocol of CB-CD133+ cells. Furthermore we evaluated the role of MSC from children’s bone marrow in the ex vivo expansion of haematopoietic stem cells (CB and BM). Materials and Methods The iosolation of CD34+ cells was performed according to an immunomagnetic method following manufacturer’s instructions. The CD133+ isolation using the same methodology had no reproducibility and different experimental approaches were applied in order to improve the method. MSC cells were isolated and cultured from childrens’ bone marrow; their characterization included the evaluation of CFU-F colonies and the differentiation towards osteo-, lipo-, chondrocytes under appropriate culture conditions. The co-culture assay of CD34+ in the presence of MSC was supplemented with 2 combinations of growth factors: a) GF1: SCF, Intereukin-3 (IL-3), G-CSF, GM-CSF and b) GF2: SCF, thrombopoietin (TPO), Intereukin-6 (IL-6), Flt-3 ligand, growth factors considered to affect more primitive cell populations. The identification of the cell subpopulations was achieved by immunophenotypic analysis. The evaluation of the clonogenic capacity of the expanded hematopoietic population was performed by assessing the development CFU-GM colonies in methylcellulose cultures. The SDF-1 and Ang-1 levels in the supernatant of the cultures were determine by immunoenzymatic ELISA method and cDNA samples were tested by polymerase chain reaction for the expression of Oct-4, Sox2, and Nanog genes. Results Our study showed that a feasible and reliable isolation of CB-CD133+ cells was not achievable even when modified protocols applied. No sufficient population to further study the co-culture with MSC could be obtained. As a result the research was focused on the CD34+ cell population. Characterization of the BM-MSC. The MSC developed in the first and maintained in subsequent passages both the characteristic fibroblast-like shape and the corresponding surface markers. CFU-F assay. The MSC fraction of the mononuclear fraction yielded 5.68±0.9 colonies. In P1 the total CFU-F colonies were 38.75±4.77 and decreased in the successive passages. CD34 and CD133 isolation. The isolation of the CD34+ population by immunomagnetic method yielded a highly purified population (93.0±1.06%) while the CD133+ isolation resulted in a population of cells with a CD133 expression ranging from 10 to 85% (median 60%). Ex vivo expanded CD34+ cells and total population of HSC. The presence of MSC with a combination of growth factors yielded the highest increase of both the total cell number and the CD34+ population. The two different combinations of GF appeared to exert similar effects on the expansion of CD34+, whereas the presence of MSC alone in the culture of both CB and BM-CD34+ increased their number by 1.58±0.59 and 2.07±0.78 times respectively. However, this condition showed the lowest expansion of CD34+ cells as compared to the condition where only growth factors were added. The comparison between CB- and BM-CD34, showed greater expansion capacity of the CB-CD34 regarding both the total cell number and the CD34+ population. Immunophenotypic characteristics of the expanded populations. The percentage of CD34+ cells was higher in the absence of growth factors, regardless of the source of HSC. The preservation of primitive cell characteristics was further supported by the evaluation of the CD34+38- and CD34+33- cell subpopulations the expression of which was higher in the condition where hematopoietic cells were cultivated in the presence of MSC alone. CFU-GM development. Although the presence of MSC alone in the culture did not particularly increase the number of CD34+ cells, the population at the end of the co-culture was characterize by greater clonogenic capacity. Expression of Oct-4, Sox2 and Nanog. The MSC showed lower expression of Oct-4 and Sox2. Nanog was expressed in all the various conditions studied. Evaluation of SDF-1 and Ang-1 levels (ELISA). Both SDF1a and Angio-1 were expressed in the supernatant especially in the presence of MSC which appears to be their main source. A higher expression of SDF1a was observed in co-culture of BM-CD34 cells with MSC either alone or in combination with growth factors, compared to that of CB-CD34 with MSC cells. Discussion We assessed the effect of children’s BM-MSC and that of recombinant early- and late-acting growth factors, alone and in combination, on the proliferation, expansion, and differentiation of hematopoietic cell population derived from cord blood and bone marrow. The role of cytokines without stromal support in the expansion of HSCs has been extensively studied but results in an increased total cell number with simultaneous differentiation and maturation of the expanded population, finding confirmed herein. This is why supplementation of the coculture with MSC, seemed an attractive alternative which would promote mainly the progenitor cell expansion. We used two growth factor combinations one including mostly late acting and the second ones considered as more early acting. We observed no difference between the two GF cocktails in any of the studied parameters possibly indicative of a quite more complex cross talk among various factors and, for sure, not limited to a small number of cytokines and growth factors. In our results less differentiation occurred in cells cultured with MSC alone, than with GF or GF+MSC and also MSC and GF provide more efficient total cell proliferation. A similar finding has been reported by others who observed a more efficient expansion of CD34+ cells when CB-CD34 were supplemented with combination of MSC and a variety of growth factors. In the literature, there is a big range of total nucleated cell expansion reported when both MSC and cytokines were present in culture and there was no difference to that observed in the presence of cytokines alone. MSC seem to preserve more the clonogeneic population as the frequency of the developed CFU-GM was the highest in their presence. No direct comparison can be made with the results of others as the experimental conditions (CB MNC/MSC co culture) or the result expression (colonies per cell number) are different. The relationships between HSC and the cells of the microenvironment were implied by the presence of HSC infiltrating the stroma. The study of the trypsinized cells of the feeder layer, showed an expression of CD34 and CD45 and CFU-GM development in the corresponding assays. Our results support the report of others who tried to show the significance of the cell to cell contact between HSC and stromal cells. Further research is required in order to fully clarify the importance of the intimate relationship between the two populations on the expansion and “stemness” of HSC. Oct-4, Sox2, and Nanog were selected based on the knowledge that they are involved in self-renewal and pluripotency of stem cells and are frequently used as markers for primitive cells. Our results showed that no condition modified the expression of any of the three transcription factors. Despite the fact that MSC are undifferentiated cells they had the lowest expression of the Oct4, Sox2, Nanog and were not influenced by the different culture conditions. These results are in agreement to those who recently reported the expression of Oct4, Nanog mRNA in BMMSCs to be much lower compared to pluripotent stem cells and Sox2mRNA to be minimally detected in a number of BM-MSC preparations. Reports from human adipose-derived stem cells found either no change on the expression of Nanog and Oct4 with low doses of bone morphogenetic protein (BMP) in ex vivo expansion study or Sox-2 and in addition Rex-1 to remain unaltered in a spinner flask cultivation. Earlier experiments have shown that the cross-talk between SDF-1a and its ligand participates in the homing of stem cells in their niches and repopulation of the BM. We found higher SDF-1a levels where MSC were present and difference in the levels between CB and BM cultures confirming the suggestion that SDF-1a could be among the factors playing critical role to the delayed engraftment observed in CB transplantation. It has been also reported that supernatants from in vitro-cultured CD34+ cells contained substantial amounts of SDF-1a and we indeed detected SDF-1a expression, in the cultures without MSC. Ang-1 which has been reported that may have a role in maintaining hematopoietic stem cells in a quiescent state within the BM did not exhibit any difference between our BM and CB cultures and in the various conditions tested with the requirement though,the presence of MSC in the culture. In other reports researchers were unable to detect Ang-1 in all their samples. In addition there was discrepancy with the results of the literature. They attribute them to an age-related post-transcriptional effect on the expression of proteins and to the exposure of MSC to fetal bovine serum and FGF-b. As long as our MSC culture protocol includes both FBS and FGF-b and the origin of our BM-MSC is young donors this rationale, is further supported and seems to add to the notion of age related differences of the cell performance. In many cases no direct comparison can be made with data from the literature, as there are many and major differences in the culture conditions applied. This emphasizes the need for more standardized protocols while, on the other hand, stresses the complexity of the biology even in the limited ex vivo system and possibly clarifies a very small part of it. We observed that CB-CD34 expansion produces similar results to BM-CD34 expanded cells when only stromal cells are present and no additive effect was seen in BM-CD34 when growth factors were added. Biological features of CB hematopoietic progenitors seem to provide them the potential for more successful ex vivo expansion than their BM counterparts
Language Greek
Subject CD133
CD34
Issue date 2015-07-17
Collection   School/Department--School of Medicine--Department of Medicine--Doctoral theses
  Type of Work--Doctoral theses
Permanent Link https://elocus.lib.uoc.gr//dlib/2/1/c/metadata-dlib-1441349966-575658-26348.tkl Bookmark and Share
Views 534

Digital Documents
No preview available

Download document
View document
Views : 12